SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P36
Within normal range
Average
-425.34%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | - |
| 2024 | 0.00% | - |
| 2023 | 0.00% | +100.0% |
| 2022 | -3149.30% | -1206.4% |
| 2021 | -241.07% | +72.1% |
| 2020 | -863.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |